{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04725994",
            "orgStudyIdInfo": {
                "id": "ID-VDP-103"
            },
            "organization": {
                "fullName": "Idience Co., Ltd.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer",
            "officialTitle": "An Open-Label, International, Multicenter, Phase 1b Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX (Capecitabine and Oxaliplatin) or Irinotecan in Patients With Advanced Gastric Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "study-to-assess-the-safety-tolerability-and-efficacy-of-idx-in-combination-with-xelox-or-irinotecan-in-patients-with-advanced-gastric-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-08",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-06-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2023-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-13",
            "studyFirstSubmitQcDate": "2021-01-21",
            "studyFirstPostDateStruct": {
                "date": "2021-01-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-08-07",
            "lastUpdatePostDateStruct": {
                "date": "2022-08-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Idience Co., Ltd.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is an open-label, Phase 1b study to evaluate the safety and tolerability of IDX-1197 and determine the MTD and RP2D in combination with XELOX or irinotecan in patients with advanced gastric cancer."
        },
        "conditionsModule": {
            "conditions": [
                "Gastric Cancer"
            ],
            "keywords": [
                "1197",
                "IDX-1197",
                "venadaparib"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Group 1",
                    "type": "OTHER",
                    "interventionNames": [
                        "Drug: IDX-1197+XELOX"
                    ]
                },
                {
                    "label": "Group 2",
                    "type": "OTHER",
                    "interventionNames": [
                        "Drug: IDX-1197+Irinotecan"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "IDX-1197+XELOX",
                    "description": "The dose levels will be escalated following a 3+3 dose escalation scheme.",
                    "armGroupLabels": [
                        "Group 1"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "IDX-1197+Irinotecan",
                    "description": "The dose levels will be escalated following a 3+3 dose escalation scheme.",
                    "armGroupLabels": [
                        "Group 2"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)",
                    "description": "To determine the MTD and RP2D of IDX-1197 when given in combination with XELOX or Irinotecan. This will be accomplished by the standard 3+3 dose escalation design. If 2 of the 3 to 6 patients in a particular dose level experience a DLT, the dose escalation should be stopped at this dose level, and the MTD will be determined.",
                    "timeFrame": "through study completion (Up to 12 months)"
                },
                {
                    "measure": "Dose Limiting Toxicities (DLTs)",
                    "description": "Occurrence of DLTs",
                    "timeFrame": "during the first 21-day cycle for Group 1 and through first 2 cycles (14 days each) for Group 2"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Group 1, patients with treatment-na\u00efve recurrent or advanced metastatic gastric cancer including gastroesophageal junction or upper part of the stomach.\n* Group 2, patients with recurrent or advanced metastatic gastric cancer including gastroesophageal junction or upper part of the stomach, who were treated \u22652 times with palliative chemotherapy before screening.\n* At least 1 evaluable lesion for the dose escalation part and at least 1 measurable lesion according to RECIST v1.1 for the dose expansion part.\n* Eastern Cooperative Oncology Group (ECOG) performance status \u22641.\n\nExclusion Criteria:\n\n* Symptomatic central nervous system or uncontrolled brain metastasis\n* Carcinomatous meningitis or its history.\n* For Group 1, patients who are HER 2 positive.\n* Any other concurrent uncontrolled illness including, but not limited to, active or ongoing symptomatic infection requiring IV antibiotic treatment, uncontrolled diabetes, hepatic, renal, or respiratory illness.\n* Severe or unstable angina, myocardial infarction or ischemia, symptomatic congestive heart failure, arterial or venous thromboembolism requiring coronary artery bypass graft or stent within the past 6 months or clinically significant cardiac dysrhythmia or New York Heart Association class II \\~ IV heart disease within 6 months of randomization.\n* Uncontrolled hypertension\n* Immunocompromised patients, such as patients known to be serologically positive for HIV.\n* Patients with known active Hepatitis B or C infection.\n* Patients with known active or symptomatic pneumonitis, or history of non-infectious pneumonitis requiring steroids.\n* Diagnosis of a myelodysplastic syndrome/acute myeloid leukemia or its suspicious characteristics.\n* Any unresolved clinically significant Common Terminology Criteria for Adverse Events (CTCAE) Grade \u22652 toxicity\n* Resting ECG with measurable QTcF \\> 470 msec on 2 or more time points within a 24-hour period or family history of long QT syndrome.\n* Current use of a cytochrome P3A4 inhibitor or inducer and strong uridine diphosphate (UDP)-glucuronosyltransferase 1A1 (UGT1A1) inhibitors.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Won Sik Lee",
                    "role": "CONTACT",
                    "phone": "82-2-526-3612",
                    "email": "wonsiklee@idience.com"
                },
                {
                    "name": "Minju Hong",
                    "role": "CONTACT",
                    "phone": "82-2-526-3644",
                    "email": "minju.hong@idience.com"
                }
            ],
            "locations": [
                {
                    "facility": "USC Norris Comp. Cancer Ctr Hospital",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Emory University Winship Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Hematology Oncology Clinic Baton Rouge / Sarah Cannon",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Baton Rouge",
                    "state": "Louisiana",
                    "zip": "70809",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.45075,
                        "lon": -91.15455
                    }
                },
                {
                    "facility": "Fox Chase Cancer Center",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19111",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Beijing Cancer Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Beijing",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "The Sixth Affiliated Hospital of Sun Yat-Sen University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Guangzhou",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "Shanghai East Hospital",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Shanghai",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Seoul National University Bundang Hospital",
                    "status": "RECRUITING",
                    "city": "Seongnam",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.43861,
                        "lon": 127.13778
                    }
                },
                {
                    "facility": "Asan Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital - Yonsei Cancer Center",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "asFound": "Gastric Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077146",
                    "term": "Irinotecan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000059004",
                    "term": "Topoisomerase I Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M1671",
                    "name": "Irinotecan",
                    "asFound": "Related",
                    "relevance": "HIGH"
                },
                {
                    "id": "M377",
                    "name": "Capecitabine",
                    "relevance": "LOW"
                },
                {
                    "id": "M1674",
                    "name": "Oxaliplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M29349",
                    "name": "Topoisomerase I Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}